Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.

Find the latest Vanda Pharmaceuticals Inc. (VNDA) stock quote, history, news and other vital information to help you with your stock trading and investing.

3 days ago · Vanda Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for central nervous system (CNS) …

3 days ago · A detailed overview of Vanda Pharmaceuticals Inc. (VNDA) stock, including real-time price, chart, key statistics, news, and more.

Jan 1, 2026 · Vanda Pharmaceuticals received FDA approval for Nereus for motion sickness, and its shares offer upside potential into 2026 catalysts. See why VNDA stock is a Buy.

Get the latest Vanda Pharmaceuticals Inc. (VNDA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Jan 5, 2026 · See the latest Vanda Pharmaceuticals Inc stock price (VNDA:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Jan 3, 2026 · Complete Vanda Pharmaceuticals Inc. stock information by Barron's. View real-time VNDA stock price and news, along with industry-best analysis.

Get real-time Vanda Pharmaceuticals Inc (VNDA) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

Jan 2, 2026 · Vanda said the approval marks the first time in over 40 years that a new pharmacologic treatment for motion sickness has come to market. Nereus will compete with dramamine, an over-the …